Evidence mapPaperPMID 35683028Full record

ReviewInternational journal of molecular sciences2022

Cross-Talk between the (Endo)Cannabinoid and Renin-Angiotensin Systems: Basic Evidence and Potential Therapeutic Significance.

Krzysztof Mińczuk, Marta Baranowska-Kuczko, Anna Krzyżewska, Eberhard Schlicker, Barbara Malinowska

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Krzysztof MińczukDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, ul. Mickiewicza 2A, 15-222 Białystok, Poland.
Marta Baranowska-KuczkoDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, ul. Mickiewicza 2A, 15-222 Białystok, Poland.ORCID 0000-0002-7238-2656
Anna KrzyżewskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, ul. Mickiewicza 2A, 15-222 Białystok, Poland.ORCID 0000-0001-5986-3757
Eberhard SchlickerDepartment of Pharmacology and Toxicology, University of Bonn, Venusberg-Campus 1, 53127 Bonn, Germany.
Barbara MalinowskaDepartment of Experimental Physiology and Pathophysiology, Medical University of Białystok, ul. Mickiewicza 2A, 15-222 Białystok, Poland.
Medical University of Białystok · PLUniversity of Bonn · DE

Funding

Medical University of Białystok SUB/2/DN/22/002/2213
6 · The paper itself

Abstract

This review is dedicated to the cross-talk between the (endo)cannabinoid and renin angiotensin systems (RAS). Activation of AT

Indexed as

CannabinoidsCOVID-19Angiotensin IIEndocannabinoidsHumansReceptor, Angiotensin, Type 1Receptors, AngiotensinReceptors, CannabinoidReninRenin-Angiotensin SystemAngiotensin IICannabinoidsEndocannabinoidsReceptor, Angiotensin, Type 1Receptors, AngiotensinReceptors, CannabinoidReninangiotensin 1-7angiotensin IIcannabinoidsCOVID-19endocannabinoidsRAS

Identifiers

PMID35683028
PMCPMC9181166
OpenAlexW4281661464

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.